The cannabis industry has been fueled by a new series of institutional investors and the changing tide of the public perception of the substance. This has helped to fuel a massive amount of growth that has been unparalleled by any other industry in recent times. All of this in combination has made cannabis an extremely interesting market to watch as we move toward the future. Although many investors have been watching the big names in cannabis for some time now, it seems as though there is a lot of positive news to look at when it comes to the smaller guys in the industry, and here are just a few.
One of the companies that many investors have been watching has been MariMed (NASDAQOTH:MRMD). The company has been working in several different areas of the cannabis market which makes them one of the more diverse plays when it comes to cannabis. On one side, MariMed has been working to give those in the industry a way to secure real estate to help grow the product as well as the technical expertise that is needed to undertake such an operation. According to one report “MariMed has developed cannabis facilities in five states so far — all of which are leased out to licensed growers under long-term agreements. The company is, therefore, looking to expand this thriving part of its business into additional states such as Pennsylvania, New Jersey, Michigan, Florida, and Ohio in the near future.” Many of these markets are poised to add to the billions in revenue that the industry has already had which means that cannabis is here to stay for the long run. MariMed has also been working to increase the amount of actual cannabis products that they sell which is everything from edibles to vaporizer pens. These products have helped the company to grow with a massive amount of propensity toward the future which makes them an interesting company to watch in the coming months.
The next company on the list is no stranger to cannabis as they have been one of the key players for some time now. The Hydropothecary Corporation (NASDAQOTH:HYYDF) has been working to secure various ties around the industry to help supply the Canadian market with cannabis. This has given them a great deal of exposure as the Canadian cannabis industry is set to explode in demand given the upcoming recreational availability of the product on October 17th. The company signed into a recent deal that could also help to give them as much as 34% of the market in Quebec as the future goes on. For now, Hydropothecary remains on many investors watch lists.
The last company on the list is one of the smaller guys in the industry, but one that offers a different way to invest in the market. Marapharm Ventures (MRPHF) is a “publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.” One of the aspects of Marapharm that separates them from the rest is their exposure to the U.S. market as well which continues to take off amidst new regulation going into place. The hopes are high that Marapharm can continue its success as new laws go into place around the country allowing the use of cannabis overall.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Marapharm Ventures, Midam has been paid $200,000 from the company and ZERO shares of Marapharm Ventures Inc. for a duration beginning June 27, 2018 and ending July 27, 2018. We may buy or sell additional shares of (MRPHF) in the open market at any time, including before, during or after the Website and Information, provide public
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
